Previous 10 | Next 10 |
REDWOOD CITY, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the third quarter of 2021 after the close of tr...
Blue Cross Blue Shield of Michigan and Horizon Blue Cross Blue Shield of New Jersey Issue Coverage Policies Providing Coverage for Treatment with the Zephyr® Valve Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatm...
There's a bifurcation in healthcare: the companies that are fighting COVID-19, and the companies that are not. Many of the stocks of the former have zoomed higher. But others have seen delays in their business, and COVID-19 has hurt these stocks. Some of these companies are real bargains no...
REDWOOD CITY, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) today announced the company will be participating in fireside chats at two upcoming virtual investor conferences. Pulmonx management is scheduled to participate in the 2021 V...
Positive Coverage Policy Gives Additional 34 Million People Access to Treatment with the Zephyr® Valve, a Minimally Invasive Treatment Option Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lu...
Pulmonx Corporation (LUNG) Q2 2021 Earnings Conference Call August 3, 2021 04:30 PM ET Company Participants Brian Johnston - IR, Gilmartin Group Glen French - President and CEO Derrick Sung - CFO Conference Call Participants Bob Hopkins - BofA Securities, Inc. Cecilia Furlong - Morgan Stanley...
The following slide deck was published by Pulmonx Corporation in conjunction with their 2021 Q2 earnings call. For further details see: Pulmonx Corporation 2021 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Pulmonx Corporation (NASDAQ: LUNG) Q2 2021 Earnings Call Aug 03, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Pulmonx Corporation (LUNG) Q2 2021 Earnings Call Transcript
Pulmonx (NASDAQ:LUNG): Q2 GAAP EPS of -$0.34 beats by $0.04. Revenue of $12.2M (+232.4% Y/Y) beats by $1.61M. Press Release For further details see: Pulmonx EPS beats by $0.04, beats on revenue
REDWOOD CITY, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for severe lung disease, today reported financial results for the second quarter ended June 30, 2021. ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
REDWOOD CITY, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2024 after the close of trading...
2024-06-23 01:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...